• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 64
  • 46
  • 13
  • 7
  • 6
  • 6
  • 5
  • 4
  • 2
  • 2
  • 1
  • 1
  • 1
  • Tagged with
  • 178
  • 178
  • 80
  • 77
  • 61
  • 33
  • 30
  • 30
  • 28
  • 20
  • 15
  • 14
  • 14
  • 14
  • 13
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
151

Postpartální exprese kardiovaskulárních mikroRNA - srovnání expresních hladin mezi plazmou, plazmatickými exozómy a plnou periferní žilní krví / Postpartum expression of cardiovascular disease-associated microRNAs - comparison of expression levels between plasma, plasma exosomes and whole peripheral venous blood

Ševčíková, Adéla January 2021 (has links)
MicroRNA (miRNA) are short non-coding RNA molecules that regulate gene expression at the post-transcriptional level. Many miRNAs are involved in the pathogenesis of cardiovascular diseases, which is associated with altered gene expression. This work compares miRNA gene expression profiles among various biological sources - whole peripheral venous blood (whole PB), plasma and plasma exosomes. For all tested groups combined, the expression levels of miRNA were maximal in whole PB and lowered in plasma and plasma exosomes, and the expression levels of miRNA were higher in plasma than in plasma exosomes, except miR-126-3p, which had a higher level detected in plasma exosomes compared to plasma. This work also compares expression levels of cardiovascular miRNA between women with anamnesis of gestational diabetes mellitus (GDM) and physiological gravidity 3-11 years postpartum in whole PB, plasma and plasma exosomes. In whole PB, 12 of 29 tested miRNAs were up-regulated in women with prior exposure to GDM. MiR-181a-5p was up-regulated in plasma exosomes and miR-499a-5p in plasma in women with prior exposure to GDM. The changes in whole peripheral venous blood seem to reflect the complex systemic response to the changes that occurred during the onset of GDM. Women with aberrant epigenetic profiles may...
152

Utilisation en grossesse des antidépresseurs et les risques maternels associés : focus sur le diabète gestationnel et la dépression postpartum

Dandjinou, Maëlle 12 1900 (has links)
La dépression affecte environ 20 % des femmes en âge de procréer et environ 5 % à 15 % des femmes enceintes. Les troubles anxieux, souvent concomitants de la dépression maternelle sont de l’ordre de 15 % durant la grossesse. Au cours des dernières années, l’utilisation gestationnelle des antidépresseurs s’est accrue, malgré les risques associés pour la mère et l’enfant rapportés dans la littérature. Les risques maternels tels que le risque de diabète gestationnel et de dépression postpartum ont été peu étudiés avec des résultats souvent contradictoires. De plus, les données sur l’évolution dans le temps de la prévalence de la dépression/anxiété et de l’utilisation des antidépresseurs durant la grossesse sont très peu disponibles dans la littérature. La Cohorte des Grossesses du Québec (CGQ) a été utilisée pour cette recherche et la thèse a été organisée en trois volets. Dans un premier volet, nous avons réalisé une étude descriptive pour étudier la prévalence et les tendances d’utilisation des antidépresseurs et de la dépression maternelle/anxiété durant la grossesse, sur la période allant de 1998 à 2015. La prévalence d’utilisation des antidépresseurs durant la grossesse a triplé, allant de 2,2 % en 1998 à 6,2 % en 2015, alors que la prévalence de dépression maternelle/anxiété a été multipliée par 1,3 (de 5 % en 1998 à 7 % en 2015). Le deuxième volet consistait à réaliser une étude utilisant le devis cas-témoins niché dans une cohorte pour évaluer si l’utilisation gestationnelle des antidépresseurs était associée à une augmentation du risque du diabète gestationnel. Nous avons trouvé que l’utilisation des antidépresseurs est associée à une augmentation du risque de diabète gestationnel (aOR = 1,19, IC 95% : 1,08-1,30) et particulièrement pour la venlafaxine (aOR = 1,27, IC 95% :1,09-1,49) et l’amitriptyline (aOR = 1,52, IC 95% :1,25-1,84). Le troisième volet consistait en une analyse de survie pour déterminer si différentes trajectoires d’utilisation d’antidépresseurs durant la grossesse, chez des femmes déprimées avant la grossesse pouvaient affecter le risque de dépression postpartum. Nos résultats montrent que les femmes exposées en continu durant la grossesse (aHR=1,69; IC à 95 % : 1,01-2,84), celles exposées au deuxième/troisième trimestre (aHR=2,56; 95 % CI : 1,33-4,90), et celles avec une exposition intermittente (aHR=2,41; 95 % CI : 1,59-3,66) ont un risque plus élevé de dépression postpartum que les femmes enceintes déprimées, non exposées pendant la gestation. A contrario, celles exposées uniquement au premier trimestre (aHR=1,35; IC à 95 % : 0,81-2,25) étaient moins à risque de dépression postpartum par rapport aux femmes non exposées. En conclusion, les antidépresseurs sont de plus en plus utilisés en grossesse et nous avons observé une augmentation modérée du risque de diabète gestationnel associé à leur utilisation, principalement pour la venlafaxine et l’amitriptyline. En ce qui concerne leur efficacité en vie réelle dans la prévention de la dépression postpartum, nous n’avons pas trouvé de diminution du risque pour les utilisatrices au sein d’une cohorte de femmes avec une dépression prénatale. Néanmoins, malgré certaines limites méthodologiques, ces résultats renforcent la nécessité d’une approche de traitement personnalisée pour chaque femme enceinte souffrant de dépression, afin de faire les meilleurs choix pour sa santé et celle de l’enfant à naitre. / Depression affects about 20% of women of childbearing age and about 5% to 15% of pregnant women. Anxiety disorders, often concomitant with maternal depression, are in the order of 15% during pregnancy. In recent years, gestational use of antidepressants has increased, despite the associated risks to mother and child reported in the literature. Maternal risks such as the risk of gestational diabetes and postpartum depression have been little studied with often contradictory results. In addition, data on the evolution over time of the prevalence of depression / anxiety and the use of antidepressants during pregnancy are very limited in the literature. The Quebec Pregnancy Cohort (QPC) was used for this research and the thesis was organized in three parts. In a first part, we carried out a descriptive study to determine the prevalence and the trends of use of antidepressants and maternal depression / anxiety during pregnancy. over the period from 1998 to 2015. We observed that the prevalence of antidepressants use during pregnancy has tripled, ranging from 2.2% in 1998 to 6.2% in 2015, while the prevalence of maternal depression / anxiety has increased by 1.3 (from 5% in 1998 to 7% in 2015). The second part consisted of carrying out a study using the nested case-control design to assess whether the gestational use of antidepressants was associated with an increased risk of gestational diabetes. We have found that the use of antidepressants is associated with an increased risk of gestational diabetes (aOR = 1.19, 95% CI: 1.08-1.30) and particularly for venlafaxine (aOR = 1.27, 95% CI: 1.09-1.49) and amitriptyline (aOR = 1.52, 95% CI: 1.25-1.84). The third part consisted of a survival analysis to determine whether different trajectories of antidepressant use during pregnancy in women depressed before pregnancy could affect the risk of postpartum depression. Our results show that women exposed continuously during pregnancy (aHR = 1.69; 95% CI: 1.01-2.84), those exposed in the second / third trimester (aHR = 2.56; 95% CI: 1.33-4.90), and those with intermittent exposure (aHR = 2.41; 95% CI: 1.59-3.66) have a higher risk of postpartum depression than depressed pregnant women, not exposed during gestation. Conversely, those exposed only in the first trimester (aHR = 1.35; 95% CI: 0.81-2.25) were less at risk of postpartum depression compared to unexposed women. In conclusion, antidepressants are increasingly used in pregnancy and we have observed a moderate increase in the risk of gestational diabetes associated with their use, mainly for venlafaxine and amitriptyline. Regarding their real-life efficacy in preventing postpartum depression, we found no decreased risk for users in a cohort of women with prenatal depression. Nonetheless, despite some methodological limitations, these results reinforce the need for a personalized treatment approach for each pregnant woman with depression, in order to make the best choices for her health and that of the unborn child.
153

The Impact of Gestational Diabetes on Maternal and Cord Blood Lipids Among Prenatal Care Patients in Western Ma

Raj, Preethi 01 January 2012 (has links) (PDF)
Gestational diabetes mellitus (GDM), a pregnancy-induced metabolic disorder that affects 2-10% of pregnancies poses future risk for diabetes mellitus (DM) and cardiovascular disease in mother and child. However, few prospective studies have examined the effect of GDM on altered maternal and cord blood lipids, specifically HDL, LDL, triglycerides, and total cholesterol, both during and after pregnancy. We have evaluated the association between GDM and lipid metabolism in pregnant mothers and their infants using data from a prospective cohort study conducted at Baystate Medical Center’s Wesson Women and Infant’s Unit. GDM was assessed prenatally by 3-hr GTT blood samples and was confirmed by obstetrician review. Lipids were assessed via fasting and non-fasting blood samples obtained during 3-hr GTTs performed at 24-28 weeks of gestation and 6-8 weeks post-partum. Data for covariates were collected via an interview form administered at the time of recruitment. We used multivariable linear regression to evaluate the association between GDM status and maternal lipids during and after pregnancy as well as cord lipids. These study results inform future research on GDM as a risk factor for future metabolic disorders in mother and child.
154

Gestational diabetes mellitus among foreign-born women in Sweden: A register-based study on the role of income.

Sharmin, Shayla, Usama, Muhammad January 2023 (has links)
Aim:  The present study aimed to determine if foreign-born women from different countries of birth have a greater risk of GDM compared to Swedish-born women and to what extent income might mediate this relationship. Methods: This cross-sectional type study included 835279 women, of which 151,642 were foreign-born and 683637 were Swedish-born women who gave birth to their first singleton child in Sweden between 1997 to 2016. Register data from the Swedish Medical Birth Register, the Swedish Total Population Register, and the Longitudinal Integrated Database for Health Insurance and Labour Market Studies was used. Multiple Logistic Regression analysis and the Karlson-Holm-Breen methods were used to explore the relationship between GDM and country of birth and to estimate the proportion of the association explained by income. Results:  Foreign-born women demonstrated higher odds ratios for developing GDM than Swedish-born women. South East Asian women showed the highest risk of GDM (OR: 4.40, CI: 4.01-4.81) followed by Africa (OR: 3.42, CI: 3.07-3.81) and Middle East & North Africa (OR: 2.92, CI: 2.67-3.20) respectively. Income partially explained the risk of GDM differences between foreign-born and Swedish-born women, accounting for 26% of the association. However, the proportion explained by income varies from 8.9% to 23.0% by country of birth. Conclusions:  A disparity exists in the risk of GDM based on country of birth, and Foreign-born women are more likely to have GDM and need additional support, including prenatal care and treatment. Since income only partially explains this association, other factors that may explain the association need to be explored.
155

The Association of Genetic and Dietary Exposures with Gestational Diabetes Mellitus Risk

Ha, Vanessa January 2019 (has links)
Background: Although lifestyle modification is the cornerstone of GDM management, the evidence base on which dietary recommendations to prevent GDM is diverse and has not been synthesized in a consistent fashion. Objectives: The overall objective of this thesis is to assess the relationship of diet patterns, foods, and nutrients with GDM risk. Specifically, we seek to: 1) Quantify the relationship between dietary factors and GDM and metabolic disorders of pregnancy; 2) Compare the effects of dietary factors on markers of glycemic control, such as fasting glucose, fasting insulin, HbA1c, and the homeostatic model assessment for insulin resistance (HOMA-IR); 3) Assess the association and interaction between carbohydrate quality, and genetic load on the risk of developing GDM using data from 2 prospective birth cohort studies. Methods: We follow the approach set by the Cochrane Group’s Handbook for Systematic Review of Interventions to conduct meta-analyses and assess the quality of the evidence using the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) approach. We analyze prospective cohort data of 2,504 women from the CHILD and START studies, which enrolled women of White-Caucasian and South Asian ethnicity. We quantify carbohydrate quality by deriving the glycemic index and load (GL), and total and added sugar intake. We construct a gene score using 102 loci that were previously associated with type 2 diabetes in genome-wide association studies. Results: 1) The meta-analysis identified high-quality evidence that red meat increases GDM risk; however, most associations of foods and nutrients with GDM and other metabolic disorders of pregnancy are of low-quality; 2) The network meta-analysis identified that most dietary interventions given with gestational weight gain advice will lower fasting glucose; 3) In South Asians, a high GL coupled with a high genetic load increased GDM risk six fold, but a high total sugar intake in the presence of a high genetic load reduced GDM risk. This paradoxical finding may be explained by a high correlation between total sugars and other healthy foods. Conclusions: Few valid associations between dietary factors and GDM risk exist. GL and total sugars may modify the genetic risk of GDM in South Asians but not in White-Caucasians. Further research is needed to determine effective interventions that can assist women in adopting healthier eating habits during pregnancy. / Thesis / Doctor of Philosophy (PhD) / Gestational diabetes mellitus (GDM) is glucose intolerance that first appears during pregnancy. Although lifestyle modification is the cornerstone of GDM management, dietary recommendations for GDM prevention are sparse. The overarching objective of this thesis is to describe the relationships between diets, foods, and nutrients and GDM and metabolic disorders of pregnancy and to understand whether carbohydrate quality can modify a genetic predisposition to diabetes. In the systematic literature reviews, high-quality evidence showed that red meat increases GDM risk. Moderate-quality evidence showed that several dietary factors also influence the risk of GDM and metabolic disorders of pregnancy, but most of the existing evidence is of low-quality. More high-quality studies are needed before dietary interventions can be implemented In our genetic study, we observed that carbohydrate quality may modify the genetic risk of diabetes in South Asians but not in White-Caucasians and conclude that carbohydrate quality may provide only a limited assessment of overall diet quality.
156

Associação do polimorfismo INS-VNTR com a susceptibilidade ao diabetes mellitus tipo 1, tipo 2 e gestacional na população urbana brasileira / Association of the INS-VNTR polymorphism with susceptibility to type 1, type 2 and gestational diabetes mellitus in the urban brazilian population

Pelá, Flávia Porto 19 October 2012 (has links)
O diabetes mellitus (DM) é definido como doença metabólica, caracterizado pela hiperglicemia, causada pela disfunção da secreção de insulina, atividade da insulina ou ambas. É classificado em quatro classes clínicas i) diabetes mellitus tipo 1 (DM1), ii) diabetes mellitus tipo 2 (DM2), iii) diabetes mellitus gestacional (DMG), iv) outros tipos específicos. Dentre os genes conhecidos por influenciarem o mecanismo de produção e liberação de insulina no organismo humano, o gene da insulina (INS) é o mais bem caracterizado nas classes clínicas do DM. A região promotora do gene INS tem sido alvo de estudo em diversas amostras populacionais do mundo, devido a sua capacidade de modular os níveis de expressão de insulina no timo e no pâncreas, de acordo, com a classe alélica que compõe o genótipo do indivíduo. Localizada a 596pb acima do sítio de transcrição do gene da insulina, é estruturada em alelos minissatélites distribuídos in tandem (ACAGGGGTGTGGGG). O alelo classe I (30 - 60 repetições) tem sido associado com predisposição ao DM1, enquanto o alelo classe III (120 - 170 repetições) tem efeito de proteção ao DM1, no entanto, esse alelo tem apresentado correlação ao DM2, à obesidade em crianças e jovens e, aumento de riscos cardiovasculares. O presente trabalho tem como objetivo analisar o polimorfismo da região promotora do gene da insulina sobre os fenótipos do DM e a possível influência desse em características demográficas, clínicas e laboratoriais desses pacientes. Foram analisados 189 pacientes com DM1, 116 pacientes com DM2, 68 pacientes com DMG e 339 indivíduos controle da região de Ribeirão Preto, SP. O DNA genômico foi extraído por salting-out, seguido da amplificação e digestão enzimática do fragmento referente a região promotora do gene INS, o qual contém na sequência downstream, o polimorfismo -23HphI, cujo desequilíbrio de ligação (r2 1) com o polimorfismo INSVNTR, permite inferir os genótipos por intermédio da análise do polimorfismo -23HphI. Observamos que o alelo classe I e o genótipo classe I : classe I estão relacionados à predisposição ao DM1, enquanto o alelo classe III, predominantemente em homozigose, está associado à proteção ao DM1. Em relação ao DM2, o genótipo classe I : classe III foi associado à susceptibilidade a doença e, nenhum genótipo foi correlacionado ao DMG. De acordo com os dados demográficos, clínicos e laboratoriais, variáveis como gênero e pigmentação da pele têm influenciado na frequência do polimorfismo INSVNTR em pacientes com DM1, como por exemplo, a maior frequência de homens com genótipo classe I : classe I no conjunto DM1. Em contrapartida, nesse mesmo grupo de pacientes, o genótipo classe III : classe III evidenciou maior susceptibilidade ao desenvolvimento de retinopatia (p=0,0020; OR= 0,05333; 95% I.C. 0,007839 - 0,3629). Em pacientes com DM2, a comparação entre gêneros evidenciou maior frequência do genótipo classe III : classe III em mulheres. E, em relação ao DMG, os genótipos de classe I : classe I e classe I : classe III estavam associados ao menor nível de glicose no plasma sanguíneo em relação as pacientes que exibiam o genótipo classe III : classe III. Esse é o primeiro estudo de associação do polimorfismo INS-VNTR comparando as três principais classes clínicas de DM oriundas de uma mesma amostra geográfica, sendo evidenciado um perfil genotípico padrão de susceptibilidade de acordo com o tipo de DM. / Diabetes mellitus (DM) is defined as a metabolic disorder characterized by hyperglycemia caused by impaired insulin secretion, insulin activity or both. It is classified into four clinical classes i) type 1 diabetes mellitus (T1DM), ii) type 2 diabetes mellitus (T2DM), iii) gestational diabetes mellitus (GDM), iv) other specific types. Among the genes known to influence the mechanism of production and release of insulin, the insulin gene (INS) has been well characterized in disease susceptibility. The INS promoter has been studied in different worldwide populations due to its ability to modulate expression levels of insulin in the thymus and pancreas, in accordance with the type of diabetes. The major polymorphic site is located 596bp upstream from the translation initiation site of the INS gene and it is structured into minisatellite alleles (ACAGGGGTGTGGGG). The shorter class I alleles (30 60 repeats) confers predisposition to DM1 and the longer class III (120 170 repeats) confers protection to DM1; however, the latter allele has also shown to be correlated with DM2, obesity in children and juvenile individuals, and increased cardiovascular risks. This study aims to analyze the association of a polymorphic site at promoter region of the INS gene with diabetes phenotypes, with the purpose of evaluating this region as a possible genetic marker of the disease, and the possible influence on demographic, clinical and laboratory features in a sample of the urban Brazilian population. We analyzed 189 T1DM patients, 116 T2DM patients, 68 GDM patients and 339 healthy individuals from the region of Ribeirão Preto, SP. DNA extraction was performed using a salting-out procedure, followed by amplification and restriction enzyme digestion of the fragment relating to INS gene promoter, which contains another polymorphism, -23HphI, which is in perfect linkage disequilibrium (r2 1) with the INS-VNTR, making it an useful genetic marker. We observed that the class I allele and class I : class I genotype are associated with predisposition to T1DM, whereas, class III allele, predominantly in homozygosity, is associated to T1DM protection. In relation to T2DM, the class I : class III genotype has been associated with susceptibility to disease. Finally, no genotype was correlated with GDM. Data stratification according to demographical, clinical and laboratory variables, indicated that gender, skin color seemed to influence the frequency of the INS-VNTR polymorphism; i. e., the class I : class I genotype was more frequent in male T1DM patients. On the other hand, the presence of the class III : class III genotype was associated with susceptibility the development of retinopathy (p=0,0020; OR= 0,05333; 95% I.C. 0,007839 - 0,3629). In T2DM patients, a trend association was observed between the class III : class III genotype with female diabetic patients. In relation to GDM, the genotypes class I : class I and class I : class III were associated with decreased glucose levels in relation to patients exhibiting the class III : class III genotype. This is the first study of the INS-VNTR polymorphism encompassing the major types if DM patients from the same geographical region, which showed a differential pattern of susceptibility according to the underlying type of DM.
157

Análise Integrativa de Perfis Transcricionais de Pacientes com Diabetes Mellitus Tipo 1, Tipo 2 e Gestacional, Comparando-os com Manifestações Demográficas, Clínicas, Laboratoriais, Fisiopatológicas e Terapêuticas / Integrative Analysis of Transcriptional Profiles in Type 1, Type 2 and Gestational Diabetes Mellitus, Compared with Demographic, Clinical, Laboratory, Physiopathology and Therapeutic Manifestations.

Evangelista, Adriane Feijó 09 March 2012 (has links)
O diabetes mellitus tipo 1 (DM1) tem etiologia autoimune, enquanto o diabetes mellitus tipo 2 (DM2) e o diabetes mellitus gestacional (DMG) são considerados como distúrbios metabólicos. Neste trabalho, foi realizada análise do transcriptoma das células mononucleares do sangue periférico (do inglês, peripheral mononuclear blood cells - PBMCs), obtidas de pacientes com DM1, DM2 e DMG, realizando análises por module maps a fim de comparar características patogênicas e aspectos gerais do tratamento com anotações disponíveis de genes modulados, tais como: a) análises disponíveis a partir de estudos de associação em larga escala (do inglês genome-wide association studies GWAS); b) genes associados ao diabetes em estudos clássicos de ligação disponíveis em bancos de dados públicos; c) perfis de expressão de células imunológicas fornecidos pelo grupo ImmGen (Immunological Project). Foram feitos microarrays do transcriptoma total da plataforma Agilent (Whole genome onecolor Agilent 4x44k) para 56 pacientes (19 DM1, 20 DM2 e 17 DMG). Para a compreensão dos resultados foram aplicados filtros não-informativos e as listas de genes diferencialmente expressos foram obtidas por análise de partição e análise estatística não-paramétrica (rank products), respectivamente. Posteriormente, análises de enriquecimento funcional foram feitas pelo DAVID e os module maps construídos usando a ferramenta Genomica. As análises funcionais contribuíram para discriminar os pacientes a partir de genes envolvidos na inflamação, em especial DM1 e DMG. Os module maps de genes diferencialmente expressos revelaram: a) genes modulados exibiram perfis de transcrição típicos de macrófagos e células dendríticas, b) genes modulados foram associados com genes previamente descritos como genes de complicação ao diabetes a partir de estudos de ligação e de meta-análises; c) a duração da doença, obesidade, número de gestações, níveis de glicose sérica e uso de medicações, tais como metformina, influenciaram a expressão gênica em pelo menos um tipo de diabetes. Esse é o primeiro estudo de module maps mostrando a influência de padrões epidemiológicos, clínicos, laboratoriais, imunopatogênicos e de tratamento na modulação dos perfis transcricionais em pacientes com os três tipos clássicos de diabetes: DM1, DM2 e DMG. / Type 1 diabetes (T1D) is an autoimmune disease while type 2 (T2D) and gestational diabetes (GDM) are considered as metabolic disturbances. We performed a transcriptome analysis of peripheral mononuclear blood cells obtained from T1D, T2D and GDM patients, and we took advantage of the module map approach to compare pathogenic and treatment features of our patient series with available annotation of modulated genes from i) genome-wide association studies; ii) genes provided by diabetes meta-analysis in public databases, iii) immune cell gene expression profiles provided by the ImmGen project. Whole genome one-color Agilent 4x44k microarray was performed for 56 (19 T1D, 20 T2D, 17 GDM) patients. Noninformative filtered and differentially expressed genes were obtained by partitioning and rank product analysis, respectively. Functional analyses were carried out using the DAVID software and module maps were constructed using the Genomica tool. Functional analyses contributed to discriminate patients on the basis of genes involved in inflammation, primarily for T1D and GDM. Module maps of differentially expressed genes revealed that: i) modulated genes exhibited transcription profiles typical of macrophage and dendritic cells, ii) modulated genes were associated with previously reported diabetes complication genes disclosed by association and meta-analysis studies, iii) disease duration, obesity, number of gestations, glucose serum levels and the use of medications, such as metformin, influenced gene expression profiles in at least one type of diabetes. This is the first module map study to show the influence of epidemiological, clinical, laboratory, immunopathogenic and treatment features on the modulation of the transcription profiles of T1D, T2D and GDM patients.
158

Diabetes mellitus gestacional : perfis glicêmicos e desfechos da gestação

Andrade, Laís Trevisan de January 2017 (has links)
Introdução e objetivos – A finalidade prioritária no tratamento do diabetes mellitus gestacional (DMG) é alcançar níveis de glicemia materna tão próximos da normalidade quanto possível, a fim de reduzir os efeitos adversos associados à hiperglicemia na gestação. A auto verificação da glicemia capilar (perfil glicêmico) é o método mais usado para a monitorização do controle metabólico na gestação complicada por diabetes. Nosso objetivo foi analisar as associações entre os perfis glicêmicos maternos com os principais desfechos da gestação numa população de mulheres com DMG acompanhadas em ambulatório de pré-natal especializado em hospital universitário no sul do Brasil, Hospital de Clínicas de Porto Alegre (HCPA). Desenho e metodotologia – conduzimos um estudo de coorte prospectiva de gestantes referidas da rede de atenção primária de saúde pública para tratamento do DMG no HCPA, acompanhadas do diagnóstico ao parto. Pesquisamos associações entre os resultados dos perfis glicêmicos com o peso de nascimento e com o risco de recém-nascidos grandes para idade gestacional e de desfechos adversos perinatais. Resultados – acompanhamos 440 mulheres com DMG. A média do índice de massa corporal (IMC) foi 33.3kg/m2. 351 bebês (79.8%) mostraram peso adequado à idade gestacional no nascimento. As médias de glicemia nos perfis pré e pósprandiais aumentaram com o avanço na categoria de peso nascimento. Três ou mais perfis glicêmicos anormais foram o fator de risco mais robusto para o nascimento de bebês grandes (OR 3.15 1.51-6.55) e para o desenvolvimento de desfechos adversos perinatais (OR 2.28 1.59-3.29). O ganho de peso materno durante o tratamento associou-se ao risco de recém-nascido grande para idade gestacional, assim como o IMC pré-gestacional, esse último também fator de risco independente para eventos perinatais adversos. Conclusão – perfis glicêmicos anormais em mais de 2 ocasiões foram o fator de risco mais relacionado ao nascimento de um bebê grande para a idade gestacional e para o desenvolvimento de complicações neonatais. Efeito benéfico do tratamento do DMG, guiado pelos perfis glicêmicos, foi a maioria de recém-nascidos com peso adequado à idade gestacional nessa coorte, apesar da incidência de desfechos perinatais adversos não ter sido diferente entre as categorias de peso fetal de nascimento. / Background and objective – a priority target in the treatment of gestational diabetes mellitus (GDM) is attaining maternal glucose levels as close as possible to euglycemia, in order to decrease the adverse outcomes linked to hyperglycemia. Self-performed capillary glucose (glycemic profile) is the most widely used method for metabolic monitoring in pregnancy complicated by diabetes. We intended to analyze the associations of maternal glycemic profile to main pregnancy outcomes in a population of GDM women treated in a specialized prenatal clinic at a university hospital in South Brazil, Hospital de Clínicas de Porto Alegre (HCPA). Research design and methodology – we conducted a prospective cohort study of pregnant women, referred from public primary health care for treatment of GDM at HCPA, between 2008 and 2015. We searched associations of glycemic profiles to birth weight, large for gestational age newborn and adverse neonatal outcomes. Results – we followed 440 GDM women from diagnosis to delivery. Mean prepregnancy body mass index (BMI) was 33.3kg/m2; 351 babies (79.8%) had appropriate birth weight for gestational age. Mean glucose in pre-prandial and postprandial profiles increased with raising birth weight category. Three or more abnormal glycemic profiles showed the strongest association to a large baby (OR 3.15 1.51-6.55) and to a composite of adverse neonatal outcomes (OR 2.28 1.59- 3.29). Gestational weight gain in the course of treatment was associated to large babies, as pre-pregnancy BMI, the latter also an independent risk factor for adverse neonatal outcome. Conclusion – abnormal maternal glycemic profiles in more than two occasions were the stronger risk factor for delivering a large baby and for developing neonatal complications. A beneficial effect of GDM treatment, guided by glycemic profiles, was that most of our newborns had birth weight appropriate for gestational age, although incidence of adverse neonatal outcomes had been no different across birth weight categories.
159

Gestational diabetes mellitus experiences of pregnant women, midwives, and obstetricians and the performance of screening /

Persson, Margareta, January 2009 (has links)
Diss. (sammanfattning) Umeå : Umeå universitet, 2009. / Härtill 4 uppsatser. Även tryckt utgåva.
160

Gestational diabetes mellitus : experiences of pregnant women, midwives, and obstetricians and the performance of screening

Persson, Margareta January 2009 (has links)
In Sweden, there is currently no consensus addressing the screening, diagnostics and treatment of gestational diabetes mellitus (GDM). In addition, there is little knowledge on the impact of GDM on the daily life of pregnant women and the experiences of health care professionals providing maternal health care to women with GDM. Using different perspectives, this thesis examines the experiences of GDM and the performance of screening for GDM in a regional context in Sweden. The studies used qualitative and quantitative methods. In the qualitative studies, grounded theory was applied in two studies and qualitative content analysis in one study. In the quantitative study, a combination of questionnaire data and data from medical records of pregnancy and birth were processed. Surprisingly, screening for GDM was reduced despite local clinical guidelines stipulating the risk factors indicating an OGTT. Furthermore, the prevalence of the risk factors for GDM in the population investigated was almost doubled compared to previous Swedish studies. Pregnant women developing risk factors for GDM during pregnancy were found to be at substantially increased risk of giving birth to an infant with macrosomia. The experiences of pregnant women with GDM revealed that being diagnosed with and living with GDM during pregnancy might be understood as a process ‘from stun to gradual balance’. The experience comprised both negative and positive dimensions. Despite the challenges, the inconveniences and the changes involved, gradually adapting to an altered lifestyle and finding their balance in daily life was ‘the prize’ the women ‘were willing to pay’ to secure optimal maternal and foetal health. The experiences of midwives comprised managing conflicting demands providing antenatal care to pregnant women diagnosed with GDM. Most midwives felt the obligation to control and monitor the complicated pregnancy, to initiate and motivate the recommended changes in life style together with providing an empowering and caring relation with the women. These assignments disclosed complex conflicting situations and the midwives appeared to choose strategy for managing the situation depending on their perception of the circumstances. The experiences of the obstetricians were understood as ‘dealing with ambiguity’. The ambiguity permeated all aspects of working as an obstetrician within the maternal health care counselling women with GDM: the role of the obstetrician, the context of the organization, balancing the multifaceted interests of the maternal and foetal conditions and the lack of consensus, recommendations and evidence-based knowledge.   The studies revealed the complexity of the situation for the affected pregnant women as well as for the health care professionals providing antenatal care to women diagnosed with GDM. Furthermore, the performance of screening of GDM in pregnant women with risk factors for GDM was insufficient in the investigated region. The findings in this thesis may be useful to increase knowledge of the experiences of pregnant women living with or managing GDM. The findings may also be useful when planning for improvements of maternal health care directed to pregnant women diagnosed with GDM during pregnancy.

Page generated in 0.1618 seconds